$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
舒尼替尼吃多久耐药?
2025-10-19 11:44:20
Check Details
舒尼替尼肾癌怎么吃?
2025-10-19 11:44:20
Check Details
舒尼替尼在肾癌中的用法用量
2025-10-19 11:44:20
Check Details
肾癌吃舒尼替尼要吃多长时间?
2025-10-19 11:44:20
Check Details
吃舒尼替尼多久有效果?
2025-10-19 11:44:20
Check Details
索拉非尼一般都多长时间耐药的
2025-10-19 11:44:20
Check Details
舒尼替尼医保的报销比例
2025-10-19 11:44:20
Check Details
舒尼替尼从哪买便宜?
2025-10-19 11:44:20
Check Details
吃索拉非尼肿瘤会缩小吗
2025-10-19 11:44:20
Check Details
索拉非尼售价多少钱一盒
2025-10-19 11:44:20
Check Details
索拉非尼药品说明书
2025-10-19 11:44:20
Check Details
替沃扎尼治疗三线及以上肾细胞癌获得完全批准
2025-10-19 11:44:20
Check Details
1
2
...
2379
2380
2381
2382
2383
2384
2385
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
2
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
7
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
8
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
9
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
10
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
11
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
12
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments